Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1717095

	registered interest
	date	10/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ritlecitinib: Shropshire
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when she expects Litfulo to be made available to NHS patients in (a) Shropshire, (b) Telford and (c) Wrekin.
	tabling member constituency	The Wrekin
	tabling member printed	Mark Pritchard
	uin	25645
	answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) makes recommendations on whether all new licensed medicines should be routinely funded by the National Health Service, based on an assessment of their costs and benefits.</p><p>On 27 March 2024, NICE published final technology appraisal guidance recommending ritlecitinib (Litfulo) for treating severe alopecia areata in people 12 years old and over. The NHS in England is legally required to fund medicines recommended by NICE within three months of the publication of its final guidance.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/05/2024 16:53:44 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	1576 label Biography information for Mark Pritchard

1717160

	registered interest
	date	10/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Joint Replacements: Post-operative Care
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that best practice guidelines for prosthetic infection are implemented across elective surgery clinical care pathways.
	tabling member constituency	Hayes and Harlington
	tabling member printed	John McDonnell
	uin	25605
	answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The Government is working with NHS England to improve perioperative care. This should ensure best practice guidelines are implemented across surgery clinical care pathways, including for prosthetic infections. In May 2023, NHS England published guidance setting out five core perioperative care requirements relating to the care of adult patients awaiting planned inpatient surgery. These measures address the key objective of identifying health needs as early as possible in perioperative pathways, and then using time on the waiting list to optimise health. The NHS England National Elective Recovery and Outpatients programme is working with NHS England regional teams to help oversee and support compliance, and will continue to do so throughout 2024/25.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/05/2024 16:56:42 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	178 label Biography information for John McDonnell

1716812

	registered interest
	date	09/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many courses of treatment were delivered by NHS general dental practitioners in each month between January 2019 to May 2024.
	tabling member constituency	Birmingham, Edgbaston
	tabling member printed	Preet Kaur Gill
	uin	25524
	answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The Dentistry Recovery Plan will make dental services faster, simpler, and fairer for patients, and will fund approximately 2.5 million additional appointments, or more than 1.5 million additional courses of dental treatment. We will further support dentists by raising the minimum Units of Dental Activity (UDA) rate to £28 this year, making National Health Service work more attractive and sustainable. NHS dental activity, as measured by Courses of Treatments delivered, has increased by 23% between 2021/22 and 2022/23. The number of UDAs commissioned and delivered is published each month on the NHS Business Services Authority Open Data Portal, which currently holds data from April 2016 to January 2024. Further information is available at the following link:</p><p><a href="https://opendata.nhsbsa.net/dataset/english-contractor-monthly-general-dental-activity" target="_blank">https://opendata.nhsbsa.net/dataset/english-contractor-monthly-general-dental-activity</a></p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 14/05/2024 13:24:49 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4603 label Biography information for Preet Kaur Gill

1716815

	registered interest
	date	09/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, which NHS dental practices were listed as accepting new NHS adult patients on 1 (a) March and (b) May 2024.
	tabling member constituency	Birmingham, Edgbaston
	tabling member printed	Preet Kaur Gill
	uin	25527
	answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>Our Dentistry Recovery Plan, backed by £200 million, will make dental services faster, simpler, and fairer for National Health Service dental patients. It will fund approximately 2.5 million additional appointments, or more than 1.5 million additional courses of dental treatment. A New Patient Premium is supporting dentists to take on new patients, and as of 8 April, nearly 500 more practices have said they are open to new patients, compared to the end of January 2024. The Find a Dentist website allows people to see which practices have said they are accepting new patients, and is available at the following link:</p><p><a href="https://www.nhs.uk/service-search/find-a-dentist" target="_blank">https://www.nhs.uk/service-search/find-a-dentist</a></p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 14/05/2024 13:20:16 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4603 label Biography information for Preet Kaur Gill

1716362

	registered interest
	date	08/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lung Cancer: Artificial Intelligence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 May 2024 to Question 24269 on Lung Cancer: Artificial Intelligence, which (a) NHS trusts have and (b) imaging network has not received funding.
	tabling member constituency	Hove
	tabling member printed	Peter Kyle
	uin	25291
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>Since the initial announcements regarding funding for National Health Service trusts to integrate artificial intelligence into lung cancer imaging, adjustments have been made to the list of participants. Three trusts have withdrawn from the initiative, and five additional trusts have been onboarded, due to the inclusion of a new imaging network. As a result, as set out in the answer of 7 May 2024, there are now 66 trusts across 12 imaging networks that are participating in this initiative.</p><p>In the answer of 7 May 2024, 63 out of 66 trusts, in 11 of 12 imaging networks, had received funding. It is now confirmed that all 66 trusts in the 12 imaging networks participating have received or are in the process of receiving funding. These trusts are currently implementing artificial intelligence technologies to enhance diagnostic capabilities in lung cancer, consistent with the Government's commitment to advancing healthcare technology across the NHS.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 13/05/2024 08:24:50 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4505 label Biography information for Peter Kyle

1716417

	registered interest
	date	08/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Maternity Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will take steps to implement the recommendations of MBRRACE-UK's report entitled Saving Lives, Improving Mothers’ Care: Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2019-21, published in October 2023.
	tabling member constituency	Oxford East
	tabling member printed	Anneliese Dodds
	uin	25319
	answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The recommendations made in the Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK’s (MBRRACE-UK) report have informed a series of work programmes to improve maternity safety. This includes ongoing work delivered through NHS England's Three-Year Delivery Plan for Maternity and Neonatal Services, which sets out how care will be made safer, more personalised, and more equitable for women, babies, and families. This is supported by an additional investment of £186 million a year to improve maternity and neonatal care, compared to 2021, on top of an additional £35 million over three years, from 2024/25 to 2026/27.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 14/05/2024 10:56:54 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4657 label Biography information for Anneliese Dodds

1716419

	registered interest
	date	08/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Maternity Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will take steps to ensure that NHS England facilitates the dissemination of the findings of the maternal, newborn and infant clinical outcome review programme delivered by MBRRACE-UK.
	tabling member constituency	Oxford East
	tabling member printed	Anneliese Dodds
	uin	25320
	answer	answer is ministerial correction date of answer 14/05/2024 answer text <p>The maternal, newborn, and infant clinical outcome review programme, delivered by Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK (MBRRACE-UK), forms part of the National Clinical Audit and Patient Outcomes Programme, which is commissioned and managed on behalf of NHS England by the Healthcare Quality Improvement Partnership.</p><p>MBRRACE-UK publishes annual data and surveillance reports on their website, and holds a national learning event to disseminate information and audit findings. NHS England supports this approach and reviews all audit recommendations after publication with a range of stakeholders. NHS England’s Three-Year Delivery Plan for Maternity and Neonatal services also highlights how NHS England will use MBRRACE-UK’s reports to monitor trends and themes at both a national and local level.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 14/05/2024 10:59:40 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4657 label Biography information for Anneliese Dodds

1716421

	registered interest
	date	08/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions she (a) has had and (b) plans to have with (i) charities and (ii) other organisations working to secure UK access to new drugs for (A) incurable, (B) relapsing and (C) remitting cancers such as myeloma.
	tabling member constituency	Birmingham, Yardley
	tabling member printed	Jess Phillips
	uin	25238
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>Department ministers and officials regularly meet with a range of organisations, with an interest in securing patient access to new cancer medicines. The National Institute for Health and Care Excellence (NICE) is the body that develops authoritative, evidence-based guidance for the National Health Service on whether new licensed medicines should be routinely funded by the NHS, based on an assessment of their costs and benefits, including medicines for myeloma. The NICE aims to publish guidance on all new medicines close to the point of licensing wherever possible, and has recommended many cancer medicines for NHS use that are now available to NHS patients, including through the Cancer Drugs Fund.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 13/05/2024 08:43:01 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4370 label Biography information for Jess Phillips

1716422

	registered interest
	date	08/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she (a) has had discussions and (b) plans to have discussions with the National Institute for Health and Care Excellence on (i) its use of the new severity modifier and (ii) how it (A) measures and (B) reports the impact of the modifier on approval of treatments for (1) cancers, (2) relapsing and remitting conditions and (3) conditions that are more prevalent in older people.
	tabling member constituency	Birmingham, Yardley
	tabling member printed	Jess Phillips
	uin	25239
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>The Department regularly meets with colleagues in the National Institute for Health and Care Excellence (NICE) to discuss a range of issues, including in relation to the NICE’s methods for the evaluation of medicines. In 2022, the NICE introduced a number of changes to make its methods and processes fairer, faster, and more consistent. This includes the introduction of a broader severity modifier, in place of the end-of-life modifier. Since the changes were introduced, 79% of the NICE’s appraisals of cancer medicines carried out under the updated methods have recommended the use of the treatment for some or all of the eligible patient population, either for routine use or use through the Cancer Drugs Fund. The approval rate for all cancer appraisals carried out since 2009, when the end-of-life modifier was introduced, is 78%.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 13/05/2024 08:48:27 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4370 label Biography information for Jess Phillips

1716479

	registered interest
	date	08/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Air Pollution: Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether her Department has made an assessment of the potential impact of household air pollution on (a) health outcomes and (b) NHS capacity and resources.
	tabling member constituency	Huddersfield
	tabling member printed	Mr Barry Sheerman
	uin	25168
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>The UK Health Security Agency published a study quantifying the health burden in the population of England from key respiratory illness or conditions associated with residential exposures to damp, mould, and formaldehyde. In 2019, the presence of damp, mould, or both was associated with approximately 5,000 cases of asthma, and approximately 8,500 lower respiratory infections among children and adults. Residential formaldehyde exposure was associated with approximately 4,000 cases of childhood asthma among children.</p><p>Exposure to indoor air pollutants can trigger or exacerbate asthma, other respiratory or cardiovascular conditions, and may even have carcinogenic effects. Damp and mould have been associated with respiratory health outcomes, such as exacerbation of asthma, respiratory infections, and allergies. The National Health Service has not made an assessment of the potential impact of household air pollution on NHS capacity and resources.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 13/05/2024 16:57:55 answering member 4492 label Biography information for Maria Caulfield
	tabling member	411 label Biography information for Mr Barry Sheerman